<?xml version="1.0" encoding="UTF-8"?>
<DoseObjectives Version="1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><Preview Version="1.2" ID="30Gy_NRG_CC001" Type="DoseObjectives" ApprovalStatus="Approved" Diagnosis="" TreatmentSite="Brain" Description="HCSWB " AssignedUsers="he-xdad\lrosa" LastModified=" May 27 2022 08:30:14:216" ApprovalHistory="he-xdad\lrosa Created [ May 25 2022 03:05:01:679 ];he-xdad\lrosa Approved [ May 25 2022 03:06:26:151 ];he-xdad\lrosa Unapproved [ May 27 2022 08:29:19:870 ];he-xdad\lrosa Approved [ May 27 2022 08:30:14:192 ]"/><Prescription Version="1.10"><MeasureItem ID="OpticChiasm"><StructureCode Code="62045" CodeScheme="FMA" CodeSchemeVersion="3.2"/><Type>5</Type><Modifier>4</Modifier><Value>30</Value><TypeSpecifier>0.03</TypeSpecifier><ReportDQPValueInAbsoluteUnits>true</ReportDQPValueInAbsoluteUnits><Priority>0</Priority><VariationAcceptable>37.5</VariationAcceptable><PrimaryClinicalGoal>false</PrimaryClinicalGoal></MeasureItem><MeasureItem ID="OpticNerve_R"><StructureCode Code="50875" CodeScheme="FMA" CodeSchemeVersion="3.2"/><Type>5</Type><Modifier>4</Modifier><Value>30</Value><TypeSpecifier>0.03</TypeSpecifier><ReportDQPValueInAbsoluteUnits>true</ReportDQPValueInAbsoluteUnits><Priority>0</Priority><VariationAcceptable>37.5</VariationAcceptable><PrimaryClinicalGoal>false</PrimaryClinicalGoal></MeasureItem><MeasureItem ID="OpticNerve_L"><StructureCode Code="50878" CodeScheme="FMA" CodeSchemeVersion="3.2"/><Type>5</Type><Modifier>4</Modifier><Value>30</Value><TypeSpecifier>0.03</TypeSpecifier><ReportDQPValueInAbsoluteUnits>true</ReportDQPValueInAbsoluteUnits><Priority>0</Priority><VariationAcceptable>37.5</VariationAcceptable><PrimaryClinicalGoal>false</PrimaryClinicalGoal></MeasureItem><MeasureItem ID="Hippocampi"><StructureCode Code="275020" CodeScheme="FMA" CodeSchemeVersion="3.2"/><Type>5</Type><Modifier>4</Modifier><Value>16</Value><TypeSpecifier>0.03</TypeSpecifier><ReportDQPValueInAbsoluteUnits>true</ReportDQPValueInAbsoluteUnits><Priority>0</Priority><VariationAcceptable>17</VariationAcceptable><PrimaryClinicalGoal>false</PrimaryClinicalGoal></MeasureItem><MeasureItem ID="Hippocampi"><StructureCode Code="275020" CodeScheme="FMA" CodeSchemeVersion="3.2"/><Type>4</Type><Modifier>4</Modifier><Value>9</Value><TypeSpecifier>100</TypeSpecifier><ReportDQPValueInAbsoluteUnits>true</ReportDQPValueInAbsoluteUnits><Priority>0</Priority><VariationAcceptable>10</VariationAcceptable><PrimaryClinicalGoal>false</PrimaryClinicalGoal></MeasureItem><MeasureItem ID="PTV_3000"><StructureCode Code="PTV_High" CodeScheme="99VMS_STRUCTCODE" CodeSchemeVersion="1.0"/><Type>3</Type><Modifier>3</Modifier><Value>95</Value><TypeSpecifier>30</TypeSpecifier><ReportDQPValueInAbsoluteUnits>false</ReportDQPValueInAbsoluteUnits><Priority>0</Priority><VariationAcceptable>90</VariationAcceptable><PrimaryClinicalGoal>false</PrimaryClinicalGoal></MeasureItem><MeasureItem ID="PTV_3000"><StructureCode Code="PTV_High" CodeScheme="99VMS_STRUCTCODE" CodeSchemeVersion="1.0"/><Type>4</Type><Modifier>3</Modifier><Value>25</Value><TypeSpecifier>98</TypeSpecifier><ReportDQPValueInAbsoluteUnits>true</ReportDQPValueInAbsoluteUnits><Priority>0</Priority><VariationAcceptable>22.5</VariationAcceptable><PrimaryClinicalGoal>false</PrimaryClinicalGoal></MeasureItem><MeasureItem ID="PTV_3000"><StructureCode Code="PTV_High" CodeScheme="99VMS_STRUCTCODE" CodeSchemeVersion="1.0"/><Type>4</Type><Modifier>4</Modifier><Value>37.5</Value><TypeSpecifier>2</TypeSpecifier><ReportDQPValueInAbsoluteUnits>true</ReportDQPValueInAbsoluteUnits><Priority>0</Priority><VariationAcceptable>40</VariationAcceptable><PrimaryClinicalGoal>false</PrimaryClinicalGoal></MeasureItem></Prescription></DoseObjectives>
